776 | When do | theellasmith | 11/15/2012 6:28:12 AM |
775 | I think so, too. PTSH will score big in the | theellasmith | 11/15/2012 6:26:03 AM |
774 | Little push I think PTSH just needs a | aleksdavis | 11/15/2012 6:24:26 AM |
773 | Yesterd | aleksdavis | 11/15/2012 6:12:56 AM |
772 | Thats w | aleksdavis | 11/15/2012 6:09:55 AM |
771 | I belie | aleksdavis | 11/15/2012 6:07:02 AM |
770 | PTSH - | theellasmith | 11/15/2012 5:59:05 AM |
769 | PTSH - | theellasmith | 11/15/2012 5:55:05 AM |
768 | PTSH - | theellasmith | 11/15/2012 5:50:33 AM |
767 | Especiallyat this price.Once | judith keenan | 11/14/2012 1:20:37 PM |
766 | Definit | theellasmith | 11/14/2012 1:19:46 PM |
765 | I agree howard som | judith keenan | 11/14/2012 1:16:43 PM |
764 | Well, w | theellasmith | 11/14/2012 1:16:14 PM |
763 | Advice for short players! | Mary Johnson | 11/14/2012 1:14:28 PM |
762 | According to overall analysis | Mary Johnson | 11/14/2012 1:11:08 PM |
761 | I`m following your lead with Ptsh I am pretty | judith keenan | 11/14/2012 1:11:00 PM |
760 | I've se | theellasmith | 11/14/2012 1:10:23 PM |
759 | Accordi | Mary Johnson | 11/14/2012 1:08:00 PM |
758 | PTSH - | theellasmith | 11/14/2012 1:05:22 PM |
757 | Ptsh also may surprise everyone, not that | judith keenan | 11/14/2012 1:04:51 PM |
756 | You are | Mary Johnson | 11/14/2012 1:03:41 PM |
755 | time to get in, a 20% easy profit to | judith keenan | 11/14/2012 12:59:36 PM |
754 | PTSH - | theellasmith | 11/14/2012 12:59:08 PM |
753 | PTSH short term | mwirmm | 11/14/2012 8:08:25 AM |
752 | Excelle | mwirmm | 11/14/2012 8:06:21 AM |
751 | THanks | mwirmm | 11/14/2012 8:04:55 AM |
750 | Should | mwirmm | 11/14/2012 8:02:13 AM |
749 | Excelle | mwirmm | 11/14/2012 8:01:38 AM |
748 | PTSH is | John Howard | 11/14/2012 7:49:08 AM |
747 | I think | John Howard | 11/14/2012 7:46:18 AM |
746 | we defi | John Howard | 11/14/2012 7:44:14 AM |
745 | Everyth | John Howard | 11/14/2012 7:42:28 AM |
744 | Some of | aleksdavis | 11/14/2012 5:09:49 AM |
743 | GREEN+PTSH=$$$ Just to remind you that 2 weeks | Milly Joel | 11/14/2012 5:09:37 AM |
742 | Well, i | aleksdavis | 11/14/2012 5:01:05 AM |
741 | That means that all puzzle pieces are here, only | Milly Joel | 11/14/2012 4:55:49 AM |
740 | Well, we are in the middle of the trading week, | Milly Joel | 11/14/2012 4:52:25 AM |
739 | Agree.M | aleksdavis | 11/14/2012 4:51:12 AM |
738 | BULLS ARE STRONGER Yesterdays trading dynamic | Milly Joel | 11/14/2012 4:38:53 AM |
737 | Im expe | aleksdavis | 11/14/2012 4:35:41 AM |
736 | GREEN CLOSURE Everything was pointing to | Milly Joel | 11/14/2012 4:33:30 AM |
735 | PTSH closed green yday Price Support Pivot Point | aleksdavis | 11/14/2012 4:28:28 AM |
734 | Well ne | mwirmm | 11/13/2012 3:52:25 PM |
733 | PTSH is | mwirmm | 11/13/2012 3:50:58 PM |
732 | Its not | mwirmm | 11/13/2012 3:50:12 PM |
731 | Yeh and | mwirmm | 11/13/2012 3:49:12 PM |
730 | PTSH ne | mwirmm | 11/13/2012 3:44:57 PM |
729 | There i | Mary Johnson | 11/13/2012 3:18:17 PM |
728 | There i | Mary Johnson | 11/13/2012 3:14:18 PM |
727 | I am al | Mary Johnson | 11/13/2012 3:10:54 PM |
Recent Articles
- Canopy Growth Corporation Legal Challenge: Investors Unite
- Cytokinetics Unveils New Insights on Aficamten's Impact at Congress
- Investors Have Chance to Lead Class Action Against SVVC Fund
- Mads Mikkelsen Introduces a Unique Negroni at Cannes Festival
- Promising Two-Year Data Revealed for Nexiguran Ziclumeran Study
- Innovative Advances in CMT-SORD: Applied Therapeutics Updates
- Samaritan's Purse Mobilizes to Support Tornado-Affected Families
- Bitcoin Solaris Introduces Groundbreaking Mining Technology
- Connie Chan Takes the Helm as Chief Growth Officer at Stagwell
- Exciting Travel Offers for Adventure Seekers Unveiled
- HKPA and APTEC Unveil Innovative CTV Initiative at China Print
- Empowering Young Leaders: Live Good's Revamped Initiative
- Rescue Smokers Achieve Grand Champion Glory at SmokeSlam BBQ
- JJ's Triumph at Eurovision 2025 Marks His Rise in Music
- Exciting New Travelzoo Offers for Enthusiasts Awaiting You
- Questlove's Inspiring Graduation Speech: A Journey of Growth
- Dillard’s, Inc. Declares $0.25 Dividend for Shareholders
- XenDex Presale Ramps Up Amid XRP Price Surge: Key Developments
- Houston Boston Partnership Expands with New Automotive Allies
- Tectonic Therapeutic's TX45 Shows Promise in Phase 1b Study
- Unlocking the Power of Leverage in Crypto Trading with BexBack
- Legal Action Against Walgreen Co. for Meal Break Violations
- Investors Alert: Join the Class Action Against Sana Biotechnology
- JAMining Unveils Innovative Cloud Mining for Top Altcoins
- Artly's Barista Bot Revolutionizes Coffee Experience at NRA
- Çelebi Aviation Addresses Current Airport Operations Update
- Introducing the Bitcoin Solaris Developer API Suite
- Highlights of Week 17: Progress Under Trump’s Leadership
- TaskUs Shareholders Invited to Explore Legal Options Against Buyout
- Exploring Skechers' Recent Merger and Shareholder Concerns
- Legal Actions and Shareholder Rights: Ibotta Updates
- Assessing Legal Options for Iovance Biotherapeutics Investors
- Fractyl Health's Rejuva® Therapy Promises New Hope for Obesity
- Malai Unveils New Ice Cream Shop in Philadelphia with Flavor
- Destination XL Expands Presence with New Store Opening
- Understanding the Art of Giving for a Change in Humanity
- Çelebi Aviation's Commitment to ETHICS and Compliance
- Arcadis Achieves Key Milestones with Shareholder Support and Dividend Approval
- CHAI's Rapid Growth Positions It for Incredible Valuation Spike
- Revolutionary Advances in Treating Resistant Hypertension
- Revolutionary Advances in Hypertension Management for Patients
- GMI Cloud Expands Headquarters to Propel AI Innovation
- Important Update for Investors in Compass Diversified Holdings
- Understanding the Iovance Biotherapeutics Class Action Lawsuit
- Investors Alert: Class Action Against Viatris Inc. - VTRS
- Investors Urged to Act on NET Power Class Action Lawsuit
- Unlock Daily Passive Income with Leading Cloud Mining Firm
- Unlocking the Future of Cloud Mining with ALL4 Mining
- WuXi Biologics Celebrates Milestone Approval of Innovative Therapy
- CureGene's CG-0416: A Revolutionary Approach to Obesity Management